Taiwan Seeks Swine Flu Sample To Ramp Up Emergency Vaccine Work
This article was originally published in PharmAsia News
Taiwan officials have asked the United States to supply samples of the swine flu H1N1 strain so the nation's National Health Research Institute can begin trying to develop a vaccine. The health minister said the NHRI is able to produce vaccine in an emergency and Adimmune has a plant set to come on line by June. The plant would be the largest of its kind in Asia, capable of producing 30 million doses. (Click here for more
You may also be interested in...
Avadim Health argues National Advertising Division expects substantiation for its homeopathic topical claims at the same level FDA requires for NDAs. NAD also said although FTC’s competent, reliable scientific evidence standard is “flexible” to some degree, pain claims are held to a more rigid standard.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
The FDA has asked the company for more information to support its PoNS therapy for multiple sclerosis patients with gait deficit, including an additional analysis of clinical data and labeling modifications.